Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$9.3M
+109.9% from 2023
Prescriptions
376
$24,779.97 per claim
Patients
74
60 prescribers
Total spending, 2024
$9.4M
$125,840.77 per patient
Medicare prescription drug plans paid $9.3M for Padcev in 2024, for 376 prescriptions and refills to 74 patients (up 109.9% from 2023). The average cost per claim was $24,779.97.
Texas had the highest Medicare cost for Padcev in 2024: $2.1M for 65 claims, followed by California ($2.0M).
Rohit Kapoor, hematology-oncology in Live Oak, TX, had the highest Medicare cost for Padcev in 2024: 52 claims costing $1.7M.
Padcev is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Seagen/Pfizer.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Rohit Kapoor Live Oak, TX | Hematology-Oncology | 52 | Under 11 | $1.7M |
| Ahmed M Ali Washington, DC | Hematology-Oncology | 13 | Under 11 | $489K |
| Youram Nassir |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 18 | 82 | 19 | $2.8M |
| 2023 | 37 | 133 | 42 | $4.4M |
| 2024 | 60 | 376 | 74 | $9.3M |
Spending by manufacturer as listed in the spending data
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology |
| 15 |
| Under 11 |
| $448K |
| Raymond Elsoueidi Hazard, KY | Hematology-Oncology | 37 | Under 11 | $397K |
| Christine G Simone Stuart, FL | Hematology-Oncology | 13 | Under 11 | $377K |
| Vaseem S Akhtar Okeechobee, FL | Medical Oncology | 14 | Under 11 | $315K |
| Tina A Khair Gettysburg, PA | Hematology-Oncology | 14 | Under 11 | $232K |
| Sanjaykumar J Hapani Edmond, OK | Medical Oncology | 12 | Under 11 | $186K |
| Odeth Barrett-Campbell Beckley, WV | Hematology-Oncology | 11 | Under 11 | $166K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Seagen/Pfizer PFE | 381 | $9.4M |